gbr 12935 has been researched along with Acute Confusional Senile Dementia in 2 studies
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, PO | 1 |
| Rinne, J | 1 |
| Marcusson, JO | 2 |
| Allard, P | 1 |
| Alafuzoff, I | 1 |
| Carlsson, A | 1 |
| Eriksson, K | 1 |
| Ericson, E | 1 |
| Gottfries, CG | 1 |
2 other studies available for gbr 12935 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Humans; Ligands; Parkinson Disease; Piperazines; Putamen; Receptors, Dopami | 1994 |
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
Topics: Aged; alpha-Methyltyrosine; Alzheimer Disease; Dopamine; Female; Homovanillic Acid; Humans; In Vitro | 1990 |